Higher Serum Soluble TREM2 as a Potential Indicative Biomarker for Cognitive Impairment in Inadequately Controlled Type 2 Diabetes Without Obesity: The DOR-KyotoJ-1

OBJECTIVE: Type 2 diabetes is a risk factor for dementia. We investigated whether serum levels of soluble triggering receptor expressed on myeloid cell 2 (sTREM2), a soluble form of the cell surface receptor TREM2, were predictive of cognitive impairment in type 2 diabetes without obesity. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Masashi, Yamakage, Hajime, Muranaka, Kazuya, Yamada, Tsutomu, Araki, Rika, Ogo, Atsushi, Matoba, Yuka, Watanabe, Tetsuhiro, Saito, Miho, Kurita, Seiichiro, Yonezawa, Kazuya, Tanaka, Tsuyoshi, Suzuki, Masahiro, Sawamura, Morio, Matsumoto, Morio, Nishimura, Motonobu, Kusakabe, Toru, Wada, Hiromichi, Hasegawa, Koji, Kotani, Kazuhiko, Noda, Mitsuhiko, Satoh-Asahara, Noriko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110765/
https://www.ncbi.nlm.nih.gov/pubmed/35592778
http://dx.doi.org/10.3389/fendo.2022.880148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110765/
https://www.ncbi.nlm.nih.gov/pubmed/35592778
http://dx.doi.org/10.3389/fendo.2022.880148

Ejemplares similares